IRIS
EMDIN, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 28.726
EU - Europa 19.166
AS - Asia 3.544
Continente sconosciuto - Info sul continente non disponibili 150
SA - Sud America 97
AF - Africa 26
OC - Oceania 19
Totale 51.728
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 27.262
GB - Regno Unito 7.314
IT - Italia 3.249
UA - Ucraina 2.435
DE - Germania 1.818
DK - Danimarca 1.574
CA - Canada 1.375
CN - Cina 1.221
VN - Vietnam 1.136
SE - Svezia 809
IE - Irlanda 707
SG - Singapore 564
FI - Finlandia 385
FR - Francia 373
HK - Hong Kong 312
PL - Polonia 261
EU - Europa 149
MX - Messico 78
PK - Pakistan 61
IN - India 49
KR - Corea 46
IR - Iran 45
SK - Slovacchia (Repubblica Slovacca) 42
NL - Olanda 38
RU - Federazione Russa 28
RO - Romania 25
CO - Colombia 23
AT - Austria 22
JP - Giappone 21
BD - Bangladesh 18
BR - Brasile 18
CH - Svizzera 17
ES - Italia 16
PE - Perù 15
AU - Australia 14
AM - Armenia 12
AR - Argentina 12
EC - Ecuador 11
ID - Indonesia 11
PT - Portogallo 11
CZ - Repubblica Ceca 10
TR - Turchia 10
BE - Belgio 8
BO - Bolivia 7
SA - Arabia Saudita 7
TH - Thailandia 7
PH - Filippine 6
HU - Ungheria 5
MG - Madagascar 5
MT - Malta 5
NZ - Nuova Zelanda 5
TW - Taiwan 5
CI - Costa d'Avorio 4
CL - Cile 4
DO - Repubblica Dominicana 4
VE - Venezuela 4
GT - Guatemala 3
HR - Croazia 3
IL - Israele 3
RS - Serbia 3
SC - Seychelles 3
TN - Tunisia 3
CR - Costa Rica 2
EG - Egitto 2
ET - Etiopia 2
GE - Georgia 2
GH - Ghana 2
GR - Grecia 2
KZ - Kazakistan 2
LT - Lituania 2
MY - Malesia 2
NG - Nigeria 2
NP - Nepal 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
DZ - Algeria 1
EE - Estonia 1
KG - Kirghizistan 1
MK - Macedonia 1
MU - Mauritius 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PY - Paraguay 1
ZA - Sudafrica 1
Totale 51.728
Salva come PNG Salva come JPEG
Città #
Southend 5.518
Woodbridge 2.864
Chandler 2.554
Ann Arbor 2.545
Houston 2.197
Fairfield 1.913
San Mateo 1.857
Falls Church 1.553
Dearborn 1.327
Seattle 1.190
Jacksonville 1.186
Cambridge 1.143
Wilmington 1.018
Ottawa 915
Ashburn 807
Boardman 697
Beijing 695
Dublin 692
Stevenage 685
Portsmouth 662
Dong Ket 641
Lawrence 525
Pisa 462
Montréal 406
Singapore 271
Warsaw 254
San Diego 213
Brooklyn 197
Rome 169
Milan 161
Redwood City 160
Old Bridge 158
London 143
Central District 114
Fremont 91
Hong Kong 90
Norwalk 85
Florence 78
Helsinki 76
Munich 73
Washington 61
Los Angeles 53
Guangzhou 52
Assago 50
Shenzhen 49
Livorno 44
Bratislava 42
Shanghai 41
Wayne 41
Bologna 38
West Jordan 38
Genoa 35
Buti 34
Seoul 34
Chiswick 30
Hounslow 29
Frankfurt am Main 27
Kilburn 26
Nanjing 26
Lucca 25
Wandsworth 25
Augusta 24
Foggia 24
Palermo 24
Hanover 23
Naples 23
Padova 23
Dallas 22
Kansas City 22
Serra 22
Dongguan 21
Simi Valley 21
Toronto 20
Fuzhou 19
Lappeenranta 19
Provo 19
Islamabad 18
Parma 18
Turin 18
Kish 17
Nuremberg 17
Amsterdam 16
Redmond 16
Bari 15
Kunming 15
Verona 15
Cascina 14
Chicago 14
Forlì 14
Hefei 14
Islington 14
Mexico 14
Salerno 14
Krefeld 13
Medellín 13
Medolago 13
Pesaro 13
Berlin 12
Brescia 12
Lima 12
Totale 37.862
Salva come PNG Salva come JPEG
Nome #
La neuropatia diabetica 234
A cross-correlational analysis between electroencephalographic and end-tidal carbon dioxide signals: Methodological issues in the presence of missing data and real data results 228
Intelligent data retrieval system as a decision support in cardiology in an Intranet environment 217
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging 215
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy. 208
E-Health in Tuscany Inner Areas: The PROXIMITY-CARE Approach 207
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 189
Evaluation of the analytical performance of the advanced method for cardiac troponin I for the AxSYM platform: comparison with the old method and the Access system. 187
Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform 183
Comparison of Brain Natriuretic Peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure 171
Usefulness of high-sensitive troponin elevation after effort stress to unveil vulnerable myocardium in patients with hart failure 171
Influence of preload and afterload on stroke volume response to low-dose dobutamine stress in patients with non-ischemic heart failure: A cardiac MR study 169
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 168
Incremental prognostic value of myocardial fibrosis in patients with non-ischemic cardiomyopathy without congestive heart failure 167
Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study 167
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 166
Nuovi strumenti di management per la gestione integrata dei percorsi assistenziali dei pazienti cronici 165
Treating chemoreflex in heart failure: modulation or demolition? 164
Development of an Electronic Medical Record for Patient Care in Cardiology 164
Medical record System for Cardiology and Cardiac Surgery 161
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 160
Building medical knowledge from real world registries: The case of heart failure 160
Cartella clinica automatizzata per il reparto di cardiologia 159
Prognostic Value of Indeterminable Anaerobic Threshold in Heart Failure. 159
Breathing Not Properly in the oldest old. Is brain natriuretic peptide a poor test for the diagnosis of heart failure in the elderly? 158
Radioimmunoassay for plasma C-type natriuretic peptide determination: a methodological evaluation 157
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 157
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease. 157
B-type natriuretic peptide secretion following scuba diving 156
Valutazione delle caratteristiche analitiche di un nuovo metodo di dosaggio del BNP 156
Role of tissue characterization by Cardiac Magnetic Resonance in the diagnosis of constrictive pericarditis 156
Severe heart failure prognosis evaluation for transplant selection in the era of beta-blockers: role of peak oxygen consumption 155
Development of an Electronic Medical Record System for the Department of Cardiology 153
Attivazione adrenergica e deattivazione parasimpatica nello scompenso cardiaco. 153
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure 153
Clinical relevance of non-cardiac determinants of natriuretic peptide levels. 152
Abnormal T2-STIR magnetic resonance in hypertrophic cardiomyopathy: A marker of advanced disease and electrical myocardial instability 152
The heart after idarubicin overdose. Cardiac death in a patient with acute promyelocitic leukaemia 152
An Open System for Managing Long Term ECG Recordings 151
Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay of the N-terminal fragment of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide. 150
Prognostic value of combined use of B-ype natriuretic peptides and interleukine-6 in predicting cardiac mortalità in end-stage renal disease patients 150
Renal function and peak exercise oxygen consumption in chronic heart failure with reduced left ventricular ejection fraction 150
Valutazione esterna di qualità dei peptidi natriuretici BNP e NT-proBNP: risultati del programma Cardioormocheck 149
These abstracts have been selected for moderated presentations on SCREEN A. Please refer to the the PROGRAM and the infos on the screen for more details about schedule, moderators and presenters. 149
Usefulness of High-Sensitive Troponin Elevation After Effort Stress to Unveil Vulnerable Myocardium in Patients With Heart Failure 149
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 149
Preliminary usability assessment for a novel robotic interface for remote Doppler-echocardiography 149
Influence of gender on circulating cardiac natriuretic hormones in patients with heart failure. 148
Response to letters regarding article, "Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study" 148
Natriuretic peptides (NPs): Automated electrochemiluminescent immunoassay for N-terminal pro-BNP compared with IRMAs for ANP and BNP in heart failure patients and healthy individuals. 147
Usefulness of late gadolinium enhancement MRI combined with stress imaging in predictive significant coronary stenosis in new-diagnosed left ventricular dysfunction 147
Fibrosis and mortality in patients with dilated cardiomyopathy [2] 147
Prognostic Impact of QRS Axis Deviation in Patients Treated with Cardiac Resynchronization Therapy 147
Cardiac production of C-type natriuretic peptide in heart failure. 146
Myocardial damage in a mitochondrial myopathy patient with increased ergoreceptor sensitivity and sympatho-vagal imbalance 146
Aortic elasticity indices by magnetic resonance predict progression of ascending aorta dilation 146
Deceptive meaning of oxygen uptake measured at the anaerobic threshold in patients with systolic heart failure and atrial fibrillation 145
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 145
Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: New challenges and perspectives 145
Cocaine assumption and transient myocardial edema in asymptomatic cocaine heavy-users 144
A simple method for measuring baroreflex sensitivity holds prognostic value in heart failure 144
Analytical performance and clinical results of a fully automated MEIA system for brain natriuretic peptide assay: comparison with a point of care testing method 144
Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis 143
Inhibition of Galectin-3 Pathway Prevents Isoproterenol-Induced Left Ventricular Dysfunction and Fibrosis in Mice 143
Cheyne-Stokes Respiration, Chemoreflex, and Ticagrelor-Related Dyspnea 143
Influence of ScaI and Natriuretic Peptide (NP) Clearance Receptor Polymorphisms of the NP System on NP Concentration in Chronic Heart Failure. 142
Exercise intolerance in chronic heart failure: mechanisms and therapies. Part I. 142
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 142
Different substrates of non-sustained ventricular tachycardia in post-infarction patients with and without left ventricular dilatation. 141
Can we measure how hot the plaque is? Not yet, but…. 141
ST segment/heart rate hysteresis improves the diagnostic accuracy of ECG stress test for coronary artery disease in patients with left ventricular hypertrophy 141
Distribution of plasma cardiac troponin-I values in healthy subjects: pathophysiological considerations 140
N-terminal proB-type natriuretic peptide (NT-proBNP) is superior to BNP for the detection of eraly/mild forms of heart failure 140
Update sui biomarcatori nello scompenso cardiaco. 140
Predicting readmissions after hospitalization for heart failure: Medical reasoning vs calculators 140
C-type natriuretic peptide and heart failure 139
Asymmetrical myocardial expression of natriuretic peptides in pacing-induced heart failure. 139
The circulating levels of cardiac natriuretic hormones in healthy adults: effects of age and sex 139
Changes in chemoreflex characteristics following acetazolamide administration in patients with chronic heart failure and Cheyne Stokes respiration 139
State of the art of aldosterone immunoassays. A multicenter collaborative study on the behalf of the Cardiovascular Biomarkers Study Group of the Italian Section of European Society of Ligand Assay (ELAS) and Società Italiana di Biochimica Clinica (SIBIOC). 139
Refractory hyperaldosteronism in heart failure is associated with plasma renin activity and angiotensinogen polymorphism 139
Prognostic value of alveolar volume in systolic heart failure: a prospective observational study 139
N-terminal prob-type natriuretic peptide is a marker of vascular remodelling and subclinical atherosclerosis in asymptomatic hypertensives 139
Daptomycin concentrations in valve tissue and vegetation in patients with bacterial endocarditis 139
N-terminal fragment of B-type natriuretic peptide predicts coexisting subclinical heart and vessel disease 139
Comparison of the diagnostic accuracy of BNP and NT-proBNP in acute and chronic heart failure. Reply Letter 138
b-Gamma-glutamyltransferase activity in human vulnerable carotid plaques. 138
CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy 138
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 138
Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure. 137
New and emerging biomarkers of heart failure 136
Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides 136
Expression of C-type natriuretic peptide and of its receptor NPR-B in normal and failing heart. 135
Gamma-glutamyltransferase as a cardiovascular risk factor. 134
Natriuretic peptide testing in primary care patients. 134
Comparison of the Diagnostic Accuracy of Brain Natriuretic Peptide (BNP) and the N-Terminal Part of the Propeptide of BNP Immunoassays in Chronic and Acute Heart Failure: A Systematic Review 134
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals. 134
The metabolic exercise test data combined with Cardiac and Kidney Indexes (MECKI) score and prognosis in heart failure. A validation study 134
Neuro-hormonal activation predicts ventilatory response to exercise and functional capacity in patients with heart failure. 133
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liverdisease. 133
Totale 15.301
Salva come PNG Salva come JPEG
Categoria #
all - tutte 308.412
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 308.412
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.858 0 235 368 465 1.055 897 951 286 687 117 146 651
2020/202111.798 966 1.246 530 894 633 1.601 1.075 605 923 664 1.040 1.621
2021/20228.856 788 1.557 404 889 180 250 922 1.669 502 941 138 616
2022/20235.887 547 376 172 845 776 931 52 486 1.037 118 330 217
2023/20244.142 345 129 800 249 173 445 352 194 212 202 162 879
2024/2025467 265 202 0 0 0 0 0 0 0 0 0 0
Totale 52.512